A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
Clinical trial NCT04552535 · COMPLETED
Trial details
- NCT number
- NCT04552535
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-05-18
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.